A multicenter, prospective, randomized, subject blinded comparative study of Axoguard nerve Cap® and neurectomy for the treatment of symptomatic neuroma and prevention of recurrent end-neuroma pain (REPOSE)
Elsevier ·
The publisher did not provide an abstract — full text is available via the link below.
A multicenter, prospective, randomized, subject blinded comparative study of Axoguard nerve Cap® and neurectomy for the treatment of symptomatic neuroma and prevention of recurrent end-neuroma pain (REPOSE). // The Journal of Foot & Ankle Surgery. – URL: https://www.sciencedirect.com/science/article/pii/S1067251626001833?dgcid=rss_sd_all
A multicenter, prospective, randomized, subject blinded comparative study of Axoguard nerve Cap® and neurectomy for the treatment of symptomatic neuroma and prevention of recurrent end-neuroma pain (REPOSE). The Journal of Foot & Ankle Surgery. https://www.sciencedirect.com/science/article/pii/S1067251626001833?dgcid=rss_sd_all
“A multicenter, prospective, randomized, subject blinded comparative study of Axoguard nerve Cap® and neurectomy for the treatment of symptomatic neuroma and prevention of recurrent end-neuroma pain (REPOSE).” The Journal of Foot & Ankle Surgery.
@article{article32775,
title = {A multicenter, prospective, randomized, subject blinded comparative study of Axoguard nerve Cap® and neurectomy for the treatment of symptomatic neuroma and prevention of recurrent end-neuroma pain (REPOSE)},
journal = {The Journal of Foot \& Ankle Surgery},
url = {https://www.sciencedirect.com/science/article/pii/S1067251626001833?dgcid=rss_sd_all}
}